Similarly, the proportion of CD4+ T helper 1 (TH1) effectors increased relative to regulatory CD4+ TREG cells in intermediate (D14) and late stage (D21) tumours (decreasing CD4+FoxP3+/CD4+T-bet+ ratio, Figure 5C). This evidence concerns the gene CD4 and neoplasm.